Oral exposure to immunostimulating drugs results in early changes in innate immune parameters in the spleen

Lydia KwastDivision of Toxicology, Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands; ;TI Pharma, Leiden, the Netherlands

Daniëlle FiechterDivision of Toxicology, Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands; ;TI Pharma, Leiden, the Netherlands

Laura KruijssenDivision of Toxicology, Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands; ;TI Pharma, Leiden, the Netherlands

Rob BleuminkDivision of Toxicology, Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands;

Irene LudwigDivision of Toxicology, Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands; ;TI Pharma, Leiden, the Netherlands

Marianne Bol-SchoenmakersDivision of Toxicology, Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands;

Joost SmitDivision of Toxicology, Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands;

Raymond PietersDivision of Toxicology, Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands; Correspondence[email protected]

show all

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Oral exposure to immunostimulating drugs results in early changes in innate immune parameters in the spleen

Articles from other publishers (2)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Oral exposure to immunostimulating drugs results in early changes in innate immune parameters in the spleen

Citations (2)

Articles from other publishers (2)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date